Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Dezima Pharma in-licenses CETP inhibitor

Jan. 23, 2013

Second milestone achieved in Genfit's metabolic disorder collaboration with Sanofi

Jan. 22, 2013

Tresiba and Ryzodeg approved for diabetes in Europe

Jan. 22, 2013

Alnylam Pharmaceuticals divulges new siRNAs

Jan. 22, 2013

EMA confirms recommendation to suspend nicotinic acid/laropiprant

Jan. 21, 2013

Research at Roche and Genentech disclose novel PC9-binding peptides

Jan. 21, 2013

YH-GKA identified as a novel glucokinase activator for treating diabetes

Jan. 21, 2013

International Stem Cell tests its hpSC-derived hepatocytes in vivo

Jan. 21, 2013

Scientists at Kissei Pharmaceutical synthesize new SGLT2 inhibitors

Jan. 18, 2013

Somatuline launched in Japan

Jan. 17, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...